These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6303264)

  • 1. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses.
    Cohen MR; Cohen RM; Pickar D; Weingartner H; Murphy DL
    Arch Gen Psychiatry; 1983 Jun; 40(6):613-9. PubMed ID: 6303264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological effects of high dose naloxone administration to normal adults.
    Cohen MR; Cohen RM; Pickar D; Murphy DL; Bunney WE
    Life Sci; 1982 Jun; 30(23):2025-31. PubMed ID: 6287138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of the endogenous opioid system.
    Pickar D; Cohen MR; Naber D; Cohen RM
    Biol Psychiatry; 1982 Nov; 17(11):1243-76. PubMed ID: 6295518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal effects of high dose naloxone in humans.
    Cohen MR; Cohen RM; Pickar D; Kreger D; McLellan C; Murphy DL
    Neuropeptides; 1985 Jul; 6(4):373-80. PubMed ID: 3930990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and endocrine effects of naloxone compared in normotensive and hypertensive patients.
    Fuenmayor N; Cubeddu L
    Eur J Pharmacol; 1986 Jul; 126(3):189-97. PubMed ID: 3758170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
    Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
    Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose naloxone in older normal subjects: implications for Alzheimer's disease.
    Tariot PN; Gross M; Sunderland T; Cohen MR; Weingartner H; Murphy DL; Cohen RM
    J Am Geriatr Soc; 1988 Aug; 36(8):681-6. PubMed ID: 3042841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of alcoholism and hypothalamic opioidergic activity.
    Wand GS; Mangold D; El Deiry S; McCaul ME; Hoover D
    Arch Gen Psychiatry; 1998 Dec; 55(12):1114-9. PubMed ID: 9862555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of naloxone on oxytocin-induced cortisol decrease in normal men.
    Coiro V; Chiodera P; Rossi G; Volpi R; Salvi M; Camellini L; Roti E
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):261-5. PubMed ID: 2982243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
    Higgins ST; Preston KL; Cone EJ; Henningfield JE; Jaffe JH
    Drug Alcohol Depend; 1992 Apr; 30(1):13-26. PubMed ID: 1591977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.
    Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K
    J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naloxone on patients with panic attacks.
    Liebowitz MR; Gorman JM; Fyer AJ; Dillon DJ; Klein DF
    Am J Psychiatry; 1984 Aug; 141(8):995-7. PubMed ID: 6087689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels.
    Leslie RD; Prescott RW; Kendall-Taylor P; Cook D; Weightman D; Ratcliffe J; Ingram MC
    Horm Metab Res; 1985 Feb; 17(2):86-9. PubMed ID: 2985486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
    Rushen J; Schwarze N; Ladewig J; Foxcroft G
    Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.
    Faden AI; Holaday JW
    J Pharmacol Exp Ther; 1980 Mar; 212(3):441-7. PubMed ID: 7359345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
    el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and interpretation of opiate antagonist trials in dementia.
    Tariot PN; Sunderland T; Murphy DL; Cohen MR; Welkowitz JA; Weingartner H; Newhouse PA; Cohen RM
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):611-26. PubMed ID: 3025928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.
    Caprio S; Gerety G; Tamborlane WV; Jones T; Diamond M; Jacob R; Sherwin RS
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E852-8. PubMed ID: 2058661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.